Market Overview:
The global infertility treatment drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infertility, rising awareness about available treatments, and technological advancements in the field of assisted reproductive technologies (ART). The global infertility treatment drugs market is segmented on the basis of type into gonadotropins, anti-estrogens, and other drugs. Gonadotropins are expected to account for the largest share of this market in 2018. This can be attributed to their high efficacy and widespread use in ART procedures. Anti-estrogens are also expected to witness significant growth during the forecast period owing to their ability to improve fertility outcomes in women with estrogen-related fertility problems. On the basis of application, this market is segmented into male and female infertility treatments.
Product Definition:
There are many types of infertility drugs, but they all have the same goal: to help you become pregnant. The most common type of infertility drug is a fertility medication. This is a drug that helps stimulate ovulation, the release of an egg from the ovary. Other types of infertility drugs include hormone therapy, which replaces hormones that are in short supply or not working properly; and surgery, which is used to treat conditions such as blocked fallopian tubes.
Gonadotropins:
Gonadotropins are a group of peptides that regulate the release of Follicle Stimulating hormone (FSH) and Luteinizing Hormone (LH). These hormones act in the brain to stimulate the ovary to produce estrogen and testosterone. Gonadotropins can be used for treatment of delayed puberty, polycystic ovary syndrome, menorrhagia, infertility due to excess prolactin levels or hypogonadism.
Anti-Estrogens:
Anti-estrogens are substances that act as weak estrogens and compete with natural estrogen for binding to the estrogen receptor. Anti-estrogenic drugs include selective oophorectomy drugs, aromatase inhibitors, and SERM's ( selective estrogen receptor modulators).
Application Insights:
The male application segment dominated the global infertility treatment drugs market in 2017. This can be attributed to increasing number of procedures for Assisted Reproduction Technology (ART) and rising awareness about available options for treating male infertility. Increasing adoption of advanced medicines by doctors, growing prevalence of Male Infertility and a rise in demand for non-invasive treatments are some factors responsible for the growth of this segment.
Female fertility is expected to witness significant growth over the forecast period due to increase in adoption of lifestyle modifications such as dietetic & nutritional supplements, weight loss programs and exercise along with an increase in number of female patients seeking assisted reproductive technology (ART). The availability of a wide range products such as ovulation induction medicine, oral contraceptives, hormone replacement therapy that help women maintain their health during pregnancy is also anticipated to boost market growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. High adoption of technologically advanced products, presence of well-established healthcare facilities and high awareness regarding various treatment options are some factors responsible for its large share. In addition, increasing government initiatives to create awareness about available treatments is also expected to propel the demand for drugs over the forecast period. For instance, Fertility Institutes of America (FIA) is a not-for-profit organization that provides egg freezing services at affordable prices through an extensive network across North America.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising infertility rate coupled with growing disposable income and improved access to healthcare facilities in emerging countries such as India and China. Moreover, increasing number of research studies being conducted on human fertility in this region will drive market growth over next eight years (2030).
Growth Factors:
- Increasing incidence of infertility: The global infertility rate has been increasing in the past few years. This is mainly due to changing lifestyles and environmental factors. This is expected to drive the demand for infertility treatment drugs in the coming years.
- Growing awareness about fertility treatments: There is a growing awareness among people about different fertility treatments available today. This is driving the demand for infertility treatment drugs worldwide.
- Advances in technology: The advances in technology have led to development of new and better drugs for treating infertility problems. This is expected to boost the growth of Infertility Treatment Drugs market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Infertility Treatment Drugs Market Research Report
By Type
Gonadotropins, Anti-Estrogens, Other
By Application
Male, Female
By Companies
Merck, Ferring, MSD, LIVZON, Abbott, Bayer, Zydus Pharma, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Infertility Treatment Drugs Market Report Segments:
The global Infertility Treatment Drugs market is segmented on the basis of:
Types
Gonadotropins, Anti-Estrogens, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Male, Female
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Ferring
- MSD
- LIVZON
- Abbott
- Bayer
- Zydus Pharma
- Merck
Highlights of The Infertility Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gonadotropins
- Anti-Estrogens
- Other
- By Application:
- Male
- Female
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infertility Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There are many different types of infertility treatment drugs. These medications can help to improve a woman's chances of becoming pregnant. Some common types of infertility treatment drugs include: fertility treatments such as in-vitro fertilization (IVF), intrauterine insemination (IUI), and intracytoplasmic sperm injection (ICSI); medications used to treat male infertility, such as testosterone therapy; and other medications that may be prescribed by your doctor based on the specific situation you are experiencing.
Some of the major players in the infertility treatment drugs market are Merck, Ferring, MSD, LIVZON, Abbott, Bayer, Zydus Pharma, Merck.
The infertility treatment drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infertility Treatment Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Infertility Treatment Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Infertility Treatment Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Infertility Treatment Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Infertility Treatment Drugs Market Size & Forecast, 2018-2028
4.5.1 Infertility Treatment Drugs Market Size and Y-o-Y Growth
4.5.2 Infertility Treatment Drugs Market Absolute $ Opportunity
Chapter 5 Global Infertility Treatment Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Infertility Treatment Drugs Market Size Forecast by Type
5.2.1 Gonadotropins
5.2.2 Anti-Estrogens
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Infertility Treatment Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Infertility Treatment Drugs Market Size Forecast by Applications
6.2.1 Male
6.2.2 Female
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Infertility Treatment Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Infertility Treatment Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Infertility Treatment Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Infertility Treatment Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Infertility Treatment Drugs Market Size Forecast by Type
9.6.1 Gonadotropins
9.6.2 Anti-Estrogens
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Infertility Treatment Drugs Market Size Forecast by Applications
9.10.1 Male
9.10.2 Female
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Infertility Treatment Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Infertility Treatment Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Infertility Treatment Drugs Market Size Forecast by Type
10.6.1 Gonadotropins
10.6.2 Anti-Estrogens
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Infertility Treatment Drugs Market Size Forecast by Applications
10.10.1 Male
10.10.2 Female
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Infertility Treatment Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Infertility Treatment Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Infertility Treatment Drugs Market Size Forecast by Type
11.6.1 Gonadotropins
11.6.2 Anti-Estrogens
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Infertility Treatment Drugs Market Size Forecast by Applications
11.10.1 Male
11.10.2 Female
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Infertility Treatment Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Infertility Treatment Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Infertility Treatment Drugs Market Size Forecast by Type
12.6.1 Gonadotropins
12.6.2 Anti-Estrogens
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Infertility Treatment Drugs Market Size Forecast by Applications
12.10.1 Male
12.10.2 Female
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Infertility Treatment Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Infertility Treatment Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Infertility Treatment Drugs Market Size Forecast by Type
13.6.1 Gonadotropins
13.6.2 Anti-Estrogens
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Infertility Treatment Drugs Market Size Forecast by Applications
13.10.1 Male
13.10.2 Female
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Infertility Treatment Drugs Market: Competitive Dashboard
14.2 Global Infertility Treatment Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Ferring
14.3.3 MSD
14.3.4 LIVZON
14.3.5 Abbott
14.3.6 Bayer
14.3.7 Zydus Pharma
14.3.8 Merck
